North America Large Molecule Bioanalytical Testing Services Market Size & Outlook

The large molecule bioanalytical testing services market in North America is expected to reach a projected revenue of US$ 1,684.3 million by 2030. A compound annual growth rate of 9.2% is expected of North America large molecule bioanalytical testing services market from 2022 to 2030.
Revenue, 2021 (US$M)
$764.6
Forecast, 2030 (US$M)
$1,684.3
CAGR, 2022 - 2030
9.2%
Report Coverage
North America

North America large molecule bioanalytical testing services market, 2018-2030 (US$M)

North

Related Markets

North America large molecule bioanalytical testing services market highlights

  • The North America large molecule bioanalytical testing services market generated a revenue of USD 764.6 million in 2021.
  • The market is expected to grow at a CAGR of 9.2% from 2022 to 2030.
  • In terms of segment, clinical was the largest revenue generating phase in 2021.
  • Preclinical is the most lucrative phase segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2022 to 2030.


North America data book summary

Market revenue in 2021USD 764.6 million
Market revenue in 2030USD 1,684.3 million
Growth rate9.2% (CAGR from 2021 to 2030)
Largest segmentClinical
Fastest growing segmentPreclinical
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPreclinical, Clinical
Key market players worldwideLabcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, North America region accounted for 47.9% of the global large molecule bioanalytical testing services market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 509.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Large Molecule Bioanalytical Testing Services Market Scope

Large molecule bioanalytical testing services market segmentation & scope
With Antibody
Without Antibody (ELISA Based Assay)
Clinical
Pharmacokinetics
ADA
Others
ADME
PD
Bioavailability
Bioequivalence
Other Tests
Oncology
Infectious Diseases
Cardiology
Neurology
Others
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)

Large Molecule Bioanalytical Testing Services Market Companies

Name Profile # Employees HQ Website

North America large molecule bioanalytical testing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 66.14% in 2021. Horizon Databook has segmented the North America large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.


North America dominated the global market for bioanalytical testing services in 2020 because it is among the top manufacturing hubs for highly reliable, complex, and high-end pharmaceuticals. Rapid technological advancements and growing demand for bioanalytical testing services are factors expected to drive the global large molecule bioanalytical testing services market.

Moreover, biopharmaceutical companies are focusing on the U.S. market due to the booming healthcare industry in the country. Increasing investments by bioanalytical testing services organizations, growing R&D spending in the biopharmaceutical industry, and favorable regulatory reforms are factors contributing to growth of the large molecule bioanalytical testing services market.

Reasons to subscribe to North America large molecule bioanalytical testing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America large molecule bioanalytical testing services market databook

  • Our clientele includes a mix of large molecule bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America large molecule bioanalytical testing services market , including forecasts for subscribers. This continent databook contains high-level insights into North America large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America large molecule bioanalytical testing services market size, by country, 2018-2030 (US$M)

North America Large Molecule Bioanalytical Testing Services Market Outlook Share, 2021 & 2030 (US$M)

North America large molecule bioanalytical testing services market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more